Pharmabiz49m
Medtronic voluntary recalls MiniMed 600 series or 700 series insulin pumps due to potential risks of shortened pump battery life
Medtronic voluntary recalls MiniMed 600 series or 700 series insulin pumps due to potential risks of shortened pump battery life: Galway, Ireland Monday, October 7, 2024, 09:00 Hr ...
Pharmabiz1h
DCA Telangana carries out 54 raids and seizes stocks worth Rs. 19.35 lakhs in September
Peethaambaran Kunnathoor, Chennai Monday, October 7, 2024, 08:00 Hrs [IST] ...
Pharmabiz1h
Indian pharma supply chain opts for ERP to accelerate efficiency in track & trace systems to facilitate compliance
Indian pharma supply chain opts for ERP to accelerate efficiency in track & trace systems to facilitate compliance: Nandita Vijayasimha, Bengaluru Monday, October 7, 2024, 08:00 H ...
Pharmabiz1h
DCC asks cosmetics industry to follow BIS standards as inclusion of INCI on cosmetics label not feasible
Gireesh Babu, New Delhi Monday, October 7, 2024, 08:00 Hrs [IST] ...
Pharmabiz1h
NABL hosts 8th conclave for proficiency testing providers and reference material producers in Mysuru
NABL hosts 8th conclave for proficiency testing providers and reference material producers in Mysuru: Shardul Nautiyal, Mumbai Monday, October 7, 2024, 08:00 Hrs [IST] The Nationa ...
Pharmabiz1h
NCCE recommends efforts to facilitate adoption of CE Act by all states
NCCE recommends efforts to facilitate adoption of CE Act by all states: Gireesh Babu, New Delhi Monday, October 7, 2024, 08:00 Hrs [IST] The National Council for Clinical Establis ...
Pharmabiz2d
Ingenza announces move to purpose-built facilities to expand fermentation and research capacity
Ingenza announces move to purpose-built facilities to expand fermentation and research capacity: United Kingdom Friday, October 4, 2024, 18:00 Hrs [IST] Ingenza, a world-leading c ...
Pharmabiz1d
Daiichi Sankyo submits Enhertu sNDA to Japan’s MHLF for patients with HER2 low or HER2 ultralow metastatic breast cancer
Daiichi Sankyo submits Enhertu sNDA to Japan’s MHLF for patients with HER2 low or HER2 ultralow metastatic breast cancer ...
Pharmabiz1d
Soligenix partners with Sterling Pharma to optimize and implement a commercially viable, scalable production technology for synthetic hypericin
Soligenix partners with Sterling Pharma to optimize and implement a commercially viable, scalable production technology for synthetic hypericin: Princeton, New Jersey Saturday, Oc ...
Pharmabiz1d
Theriva Biologics announces positive outcome of DSMC review in phase 1b/2a trial of ribaxamase in allogeneic HCT recipients
Rockville, Maryland Saturday, October 5, 2024, 18:00 Hrs [IST] ...
Pharmabiz1d
Panacell Biotech’s exosome manufacturing method patent registered as original technology
Panacell Biotech’s exosome manufacturing method patent registered as original technology: Seoul, South Korea Saturday, October 5, 2024, 16:00 Hrs [IST] Panacell Biotech Co, Ltd.
Pharmabiz1d
Palvella Therapeutics awarded up to $2.6 mn grant from US FDA OOPD to support phase 3 SELVA trial in in microcystic lymphatic malformations
Wayne, Pennsylvania Saturday, October 5, 2024, 17:00 Hrs [IST] ...